Predicting malignant potential of gastrointestinal stromal tumors: Role of p16 and E2F1 expression

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 4, 2010, Pages 338-343

  Tetikkurt, Umit Seza ^a   Ozaydin, Ipek Yildiz ^a   Ceylan, Sule ^a   Gurbuz, Yesim ^b   Erdogan, Nusret ^a   Oz, Feriha ^c  

^a Taksim Training and Research Hospital   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c Universal Hospitals Group   (Turkey)

Author keywords

E2F1; gastrointestinal stromal tumor; immunohistochemistry; Ki 67; p16

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; TRANSCRIPTION FACTOR E2F1;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL CYCLE REGULATION; CLINICAL ARTICLE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; E2F1 TRANSCRIPTION FACTOR; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; TUMOR MARKERS, BIOLOGICAL;

EID: 77954110448     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181d245c0     Document Type: Article

References (30)

1. Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459-465. (Pubitemid 34747864)
2. Yamamoto H, Oda Y, Kawaguchi K, et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 2004;28: 479-488.
3. Nakamura N, Yamamoto H, Yao T, et al. Prognostic significance of expression of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol. 2005;36:828-837.
4. Cordon-Cardo C. Molecular biology of sarcomas. In: De Vita VT, Helman S, Rosenberg SA, eds. Principles and Practice of Oncology. 5th ed. Philadelphia: JB Lippincott Company; 1997:1731-1738.
5. Schneider SR, Boltze C, Lasota J, et al. Loss of p16 protein defines high risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res. 2005;11:638-645.
6. Sabah M, Cummins R, Leader M, et al. Loss of heterozygosity of chromosome 9p and loss of p 16INK4A expression are associated with malignant gastrointestinal stromal tumors. Mod Pathol. 2004;17:1364-1371.
7. Munot K, Bell SM, Lane S, et al. Pattern of expression of gene linked to epigenetic silencing in human breast cancer. Hum Pathol. 2006;37:989-999.
8. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8-15.
9. Steigen SE, Bjerkehagen B, Haugland HK, et al. Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway. Modern Pathol. 2008;21:46-53.
10. Sabah M, Cummins R, Leader M, et al. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Hum Pathol. 2006;37: 648-655.
11. Dimri GP, Itahana K, Acosta M, et al. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor supressor. Mol Cell Biol. 2000;20:273-285.
12. Dimri GP, Hara EE, Campisi J, et al. Regulation of two E2F related genes in presenescent and senescent human fibroblasts. J Biol Chem. 1994;269:16180-16186.
13. Gorgoulis VG, Zacharatos P, Mariatos G, et al. Transcription factor E2F1 acts as a growth promoting factor and is associated with adverse prognosis in non small cell carcinomas. J Pathol. 2002;198:142-156.
14. Haller F, Gunawan B, Heydebreck AV, et al. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin Cancer Res. 2005;11:6589-6597.
15. Myettionen M, Bralley JY, Sobin LH. Mesenchymal tumors of stomach. In: Hamilton SR, Alaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics Tumors of Digestive System. Lyon: IARC Press; 2000:62-65.
16. Wong NACS, Young R, Malcomson RDG, et al. Prognostic indicators for gastrointestinal stromal tumors: a clinicopathological and immunohistochemial study of 108 resected cases of the stomach. Histopathology. 2003;43:118-126.
17. Muro-cacho CA, Cantor AB, Morgan M. Prognostic factors in malignant gastrointestinal stromal tumors. Ann Clin Lab Sci. 2000;30:239-247.
18. Panizo-Santos A, Sola I, Vega F, et al. Predicting metastatic risk of gastrointestinal stromal tumors: role of cell proliferation and cell cycle regulatory proteins. Int J Surg Pathol. 2000;8:133-144.
19. Fontana MG, Rossi E, Bassotti G, et al. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization. J Gastroenterol Hepatol. 2007;22:1754-1759.
20. Huang HY, Huang WW, Lin CN, et al. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Annals Surgical Oncol. 2006;13:1633-1644.
21. Meara RS, Cangiarella J, Simsir A, et al. Prediction of aggressiveness of gastrointestinal stromal tumors based on immunostaining with bcl-2, KI?-67 and p53. Cytopathology. 2007;18:283-289.
22. Quelle DE, Zindy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor supressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83:993-1000.
23. Sherr CJ. The INK4a/ARF network in tumor supression. Nat Rev Mol Cell Biol. 2001;2:731-737.
24. El-Rifai W, Sarlomo-Rikala M, Anderson LC, et al. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res. 2000;60:3899-3903.
25. Schneider-Stock R, Boltze C, Lasota J, et al. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors. J Clin Oncol. 2003;21:1688-1697.
26. Helin K. Regulation of cell proliferation by E2F transcription factors. Curr Opin Genet Dev. 1997;8:28-35.
27. Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Nat Genet. 1998;9: 585-593.
28. Ishida S, Huang E, Zuzan H, et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol. 2001;21:4684-4699.
29. Lukas J, Petersen BO, Holm K, et al. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A mediated growth supression. Mol Cell Biol. 1996; 16:1047-1057.
30. Wu L, Timmers C, Maiti B, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001;414:457-462.